Memories of Agent Orange

Whose homeland security?

ANNA TO BINAYAK AND TATA

A pre-emptive strike against Monsanto

American organic farmers are trying to ensure the biotech giant cannot sue them

How I stopped worrying and learned to love Fukushima

Prime Minister’s Logic

Tracking Nilekani

The Real India Story

Biodiversity—India’s other scandal

CAG slams the national biodiversity authority for allowing questionable patents

Remember the farmer?

The scientist as a babu

Rising power of the knowledge commons

By ending ownership of ideas we can banish ignorance and change human history

Bread and games in India

The new banana republic

The irrelevance of multilateralism

Rich countries gang up for a more strident intellectual property rights regime

Waking up to ACTA

The war for intellectual property

Policy of encirclement

Choking India's generics exports

Post-pandemic blues of predatory pharma

Huge stockpiles of COVID-19 vaccines and treatments, along with a steep drop in revenues, tell a sorry tale of Big Pharma’s greed   

These lethal changes in India’s patent rules

The proposed amendments are a capitulation to Big Pharma and will undermine vital public health safeguards in the law

US is finally trying to rein in drug giants

Biden government’s push to get Big Pharma to reduce the astronomical rates of prescription medicines is significant

More give than take in secret trade deals

The tight secrecy over trade negotiations means citizens are not privy to the deals that affect them directly

How companies got their way on biodiversity

Amendments to the Biodiversity Act let companies off the hook on having to share the benefits of using biological resources

Frittering away Nehru’s momentous legacy

India initiated production of critical drugs in 1951 with the aid of UN bodies to keep out patent blocks—a model we have forgotten